Literature DB >> 8946637

Risk factors for HPV DNA detection in middle-aged women.

N Muñoz1, I Kato, F X Bosch, J Eluf-Neto, S De Sanjosé, N Ascunce, M Gili, I Izarzugaza, P Viladiu, M J Tormo, P Moreo, L C Gonzalez, L Tafur, J M Walboomers, K V Shah.   

Abstract

BACKGROUND AND OBJECTIVES: Strong epidemiologic evidence indicates that human papillomavirus (HPV) is the main etiologic factor of cervical cancer. A few cohort studies suggest that most HPV infections are transient in young women and that persistent HPV infections are more common in older women. Little is known about the determinants of persistent HPV infections. The present study was aimed at increasing our knowledge about these determinants. GOALS: To identify risk factors for genital HPV DNA detection among cytologically normal middle-aged women. STUDY
DESIGN: Eight hundred ten women who participated as control subjects in three case-control studies on cervical cancer in Spain, Colombia, and Brazil were included in this study. After an interview, women underwent a gynecologic examination with collection of exfoliated cells for a Papanicolaou smear and HPV DNA detection. Human papilloma virus DNA was detected by polymerase chain reaction (PCR)-based hybridization techniques.
RESULTS: The HPV positivity rate was 10.5% in the whole population, but was higher in the areas with high incidence of cervical cancer (17% in Brazil and 13% in Colombia) than in Spain (4.9%), which is a low-risk area for cervical cancer. Age was related to the prevalence of HPV DNA in Brazil, but not in Spain and Colombia. In univariate analyses in all three countries, the prevalence of HPV DNA was positively associated with the number of lifetime sexual partners and inversely associated with the levels of family income and with age at first sexual intercourse. There was four times increase in the odds ratio (OR) of HPV infection in women who had six or more lifetime sexual partners compared with those with one or less. The use of any kind of contraceptive tended to decrease the OR for HPV detection. Their ORs ranged from 0.44 (barrier methods) to 0.48 (oral contraceptives). In Spain and Colombia, antibodies against Chlamydia trachomatis were positively associated with the prevalence of HPV DNA. In a final multivariate model, the positive associations with lifetime number of sexual partners, socioeconomic status, and C. trachomatis persisted.
CONCLUSIONS: These results support the sexual transmission of HPV and suggest that socioeconomic status and antibodies to C. trachomatis are independent predictors of HPV detection in middle-aged cytologically normal women.

Entities:  

Mesh:

Year:  1996        PMID: 8946637     DOI: 10.1097/00007435-199611000-00012

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  23 in total

1.  Concomitant Chlamydia trachomatis and human papilloma virus infection cannot be attributed solely to sexual behaviour.

Authors:  V Verhoeven; M Baay; J Weyler; D Avonts; F Lardon; P Van Royen; J B Vermorken
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-08-18       Impact factor: 3.267

2.  Association between human papillomavirus and chlamydia trachomatis infection risk in women: a systematic review and meta-analysis.

Authors:  Giulia Naldini; Chiara Grisci; Manuela Chiavarini; Roberto Fabiani
Journal:  Int J Public Health       Date:  2019-06-08       Impact factor: 3.380

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Regression of human papillomavirus intraepithelial lesions is induced by MVA E2 therapeutic vaccine.

Authors:  Ricardo Rosales; Mario López-Contreras; Carlos Rosales; Jose-Roberto Magallanes-Molina; Roberto Gonzalez-Vergara; Jose Martin Arroyo-Cazarez; Antonio Ricardez-Arenas; Armando Del Follo-Valencia; Santiago Padilla-Arriaga; Miriam Veronica Guerrero; Miguel Angel Pirez; Claudia Arellano-Fiore; Freddy Villarreal
Journal:  Hum Gene Ther       Date:  2014-12       Impact factor: 5.695

5.  Preference for Human Papillomavirus Self-Collection and Papanicolaou: Survey of Underscreened Women in North Carolina.

Authors:  Kimberly A Kilfoyle; Andrea C Des Marais; Mai Anh Ngo; LaHoma Romocki; Alice R Richman; Lynn Barclay; Noel T Brewer; Lisa Rahangdale; Jennifer S Smith
Journal:  J Low Genit Tract Dis       Date:  2018-10       Impact factor: 1.925

Review 6.  Cervical Cancer Induction Enhancement Potential of Chlamydia Trachomatis: A Systematic Review.

Authors:  Safae Karim; Tiatou Souho; Mohamed Benlemlih; Bahia Bennani
Journal:  Curr Microbiol       Date:  2018-01-22       Impact factor: 2.188

7.  Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions.

Authors:  J W Sellors; A T Lorincz; J B Mahony; I Mielzynska; A Lytwyn; P Roth; M Howard; S Chong; D Daya; W Chapman; M Chernesky
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

8.  Prevalence and predictors of human papillomavirus infection in women in Ontario, Canada. Survey of HPV in Ontario Women (SHOW) Group.

Authors:  J W Sellors; J B Mahony; J Kaczorowski; A Lytwyn; H Bangura; S Chong; A Lorincz; D M Dalby; V Janjusevic; J L Keller
Journal:  CMAJ       Date:  2000-09-05       Impact factor: 8.262

9.  Incidence, clearance and predictors of human papillomavirus infection in women.

Authors:  John W Sellors; Tina L Karwalajtys; Janusz Kaczorowski; James B Mahony; Alice Lytwyn; Sylvia Chong; Joanna Sparrow; Attila Lorincz
Journal:  CMAJ       Date:  2003-02-18       Impact factor: 8.262

10.  Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Canadian Women's HIV Study Group.

Authors:  C Hankins; F Coutlée; N Lapointe; P Simard; T Tran; J Samson; L Hum
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.